First Do No Harm: A Proposal of an Expert-Guided Framework of Surrogate Humane Endpoints in Preclinical Models of Acute Lung Injury.
First Do No Harm: A Proposal of an Expert-Guided Framework of Surrogate Humane Endpoints in Preclinical Models of Acute Lung Injury.
复制标题
首先不造成伤害:急性肺损伤临床前模型中替代人道终点专家指导框架的提案。
DOI:
10.1097/ccm.0000000000004758
复制
发表时间:
2021
影响因子:
8.8
通讯作者:
Zingarelli,Basilia
中科院分区:
文献类型:
--
作者:
Zingarelli,Basilia
The authors report that there was strong consensus among the stakeholders in considering changes in temperature and rapid and pronounced body weight loss as objective vital and clinical signs of moribund state of the experimental animals (9). Other clinical physiologic endpoints reached Delphi consensus, such as the occurrence of severe dyspnea, thoracoabdominal respiration, and wet chirping sounds, as well as physical and biochemical markers of organ failure. The two expert groups also recommended on focusing on assessment of other well-being criteria such as behavioral changes (hunched posture, signs of discomfort, and lack of response to stimulation). An important principle of animal welfare is that any disease known to cause pain and distress in humans is considered likely to cause pain and distress in animals and should be alleviated through pain management (eg, analgesia)(11). However, the authors reported that none of the publications of the systematic review provided any evidence that small animal models of ALI/ARDS would cause significant distress nor provided a rationale to support the recommendation of the use of analgesia. On the contrary, when statements on analgesics were proposed to the Delphi panel, both expert groups of scientists and laboratory animal veterinarians considered the use of analgesia of questionable benefit, since it could interfere with immunomodulatory responses of lung injury. Nevertheless, there was strong agreement from the Delphi panel that frequency of monitoring for surrogate endpoints should be increased to several times a day according to the severity of the ALI/ARDS model (9). Transparent reporting of research methods and findings is an essential component of reproducibility and offers the unequivocal evidence of scientific rigor. Despite the development of specific reporting guidelines for preclinical research, such as Animal Research: Reporting of In Vivo Experiments (ARRIVE)(12), the authors also noted that the scientific publications selected in their systematic review often lacked key information regarding the use and the rational of humane surrogate endpoints, making difficult the assessment of the validity of these endpoints. In consideration of this important issue, there was strong consensus from the Delphi panel to recommend transparency in reporting selected surrogate humane endpoints (9).A key event of the Delphi-based analysis was the opportunity for the participants to discuss face to face the evidence-based validity of the recommended humane surrogate endpoints and share the concerns of risk of bias. Overall, decreases in whole-body temperature and body weight loss were reasonably justified as early predictors of impending death (9). It is noteworthy that these two parameters have been widely used as reliable humane surrogate endpoints in a variety of rodent models of infectious disease and sepsis and have also been proposed as criteria for euthanasia by panels of experts in the field (13–15). Nevertheless, the participants of the Delphi panel carefully acknowledged that relying on a single humane surrogate endpoint may bias the recognition of animals experiencing suboptimal health and may result in premature study termination. The expert groups were instead more confident in proposing a composite score that includes both objective (body temperature and weight loss) and subjective components (behavioral markers and respiratory distress)(9). In conclusion, considering the paucity of guidelines and reporting standards relating to experimental design of small animal ALI/ARDS models, McGinn et al (9) are to be commended for undertaking this important …
登录
查看更多内容
影响因子:
8.8
作者:
Scheunemann,LeslieP;Girard,TimothyD;Leland,NatalieE
通讯作者:
Leland,NatalieE
DOI:
--
发表时间:
2013
期刊:
Journal of the American Association for Laboratory Animal Science : JAALAS
影响因子:
--
作者:
Hankenson,FClaire;Ruskoski,Nicholas;vanSaun,Marjorie;Ying,Gui-Shuang;Oh,Jaewook;Fraser,NigelW
通讯作者:
Fraser,NigelW
DOI:
--
发表时间:
2008
期刊:
影响因子:
--
作者:
H. Karaki
通讯作者:
H. Karaki
影响因子:
2.5
作者:
E. Olfert;D. Godson
通讯作者:
D. Godson
DOI:
10.1097/shk.0000000000001243
发表时间:
2019-01
期刊:
Shock (Augusta, Ga.)
影响因子:
--
作者:
Zingarelli B;Coopersmith CM;Drechsler S;Efron P;Marshall JC;Moldawer L;Wiersinga WJ;Xiao X;Osuchowski MF;Thiemermann C
通讯作者:
Thiemermann C